Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |
mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.0034 | 0.9 |
mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |